ALZHEON, INC. AMENDED AND RESTATED STOCKHOLDERS AGREEMENTStockholders Agreement • August 27th, 2018 • Alzheon, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledAugust 27th, 2018 Company Industry JurisdictionThis AMENDED AND RESTATED STOCKHOLDERS AGREEMENT (this “Agreement”), is made as of May 25, 2017, by and among Alzheon, Inc., a Delaware corporation (the “Company”), each of the investors listed on Schedule A hereto (together with any subsequent investors or transferees, who become parties hereto as “Investors” pursuant to Subsections 9.9(a) or 9.12 below, the “Investors”), and those certain stockholders of the Company listed on Schedule B (together with any subsequent stockholders or transferees, who become parties hereto as “Key Holders” pursuant to Subsection 9.9(b) or 9.12 below, the “Key Holders,” and together collectively with the Investors, the “Stockholders”).
ALZHEON, INC. AMENDED AND RESTATED STOCKHOLDERS AGREEMENTStockholders Agreement • March 16th, 2018 • Alzheon, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledMarch 16th, 2018 Company Industry JurisdictionThis AMENDED AND RESTATED STOCKHOLDERS AGREEMENT (this “Agreement”), is made as of May 25, 2017, by and among Alzheon, Inc., a Delaware corporation (the “Company”), each of the investors listed on Schedule A hereto (together with any subsequent investors or transferees, who become parties hereto as “Investors” pursuant to Subsections 9.9(a) or 9.12 below, the “Investors”), and those certain stockholders of the Company listed on Schedule B (together with any subsequent stockholders or transferees, who become parties hereto as “Key Holders” pursuant to Subsection 9.9(b) or 9.12 below, the “Key Holders,” and together collectively with the Investors, the “Stockholders”).